Literature DB >> 8149943

Non linear disposition of thiopentone following long-term infusion.

P Le Corre1, Y Malledant, M Tanguy, R Le Verge.   

Abstract

The pharmacokinetics of thiopentone administered at infusion rates ranging 4.5-11.5 mg.kg-1.h-1 for 50-130 h was studied in 6 patients with neurologic evidence of severe cerebral damage. Arterial plasma concentrations of thiopentone were measured during and after discontinuation of the infusion. The postinfusion plasma concentrations were fitted to the one compartment Michaelis-Menten model. At the end of the infusion, the level of saturation of the enzymatic systems ranged 67.0-95.7%. Vm was on average 0.93 +/- 0.57 mg.l-1.h-1. The mean plasma clearance was 2.0 +/- 1.4 ml.min-1.kg-1. The apparent half-life of the terminal phase was 5.5 +/- 3.9 h.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8149943     DOI: 10.1007/BF03188805

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  22 in total

Review 1.  Nonlinear pharmacokinetics: clinical Implications.

Authors:  T M Ludden
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

2.  Measurement of thiamylal and thiopental in plasma by electron capture and flame photometric gas-liquid chromatography.

Authors:  R H Smith; J A MacDonald; D S Thompson; W E Flacke
Journal:  Clin Chem       Date:  1977-07       Impact factor: 8.327

3.  Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited.

Authors:  D R Stanski; P O Maitre
Journal:  Anesthesiology       Date:  1990-03       Impact factor: 7.892

4.  Pharmacokinetics of i.v. and rectal methohexitone in children.

Authors:  S Björkman; J Gabrielsson; H Quaynor; M Corbey
Journal:  Br J Anaesth       Date:  1987-12       Impact factor: 9.166

5.  Mean residence time concepts for pharmacokinetic systems with nonlinear drug elimination described by the Michaelis-Menten equation.

Authors:  H Y Cheng; W J Jusko
Journal:  Pharm Res       Date:  1988-03       Impact factor: 4.200

Review 6.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

7.  The pharmacokinetics of methohexital in young and elderly subjects.

Authors:  M M Ghoneim; C K Chiang; R D Schoenwald; J K Lilburn; J Dhanaraj
Journal:  Acta Anaesthesiol Scand       Date:  1985-07       Impact factor: 2.105

8.  Pharmacokinetic properties of thiopental in two patients treated for uncontrollable seizures.

Authors:  J C Cloyd; B D Wright; D Perrier
Journal:  Epilepsia       Date:  1979-06       Impact factor: 5.864

9.  Nonlinear pharmacokinetics of the new positive inotropic agent sulmazole in the dog.

Authors:  E R Garrett; W Roth
Journal:  J Pharm Sci       Date:  1983-02       Impact factor: 3.534

10.  Pharmacokinetics and haemodynamic effects of prolonged methohexitone infusion.

Authors:  Y Le Normand; C de Villepoix; M Pinaud; J M Bernard; J P Fraboul; A Athouel; M Ribeyrol; N Beneroso; C Larousse
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

View more
  7 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Pharmacokinetic/pharmacodynamic modeling of anesthetics in children: therapeutic implications.

Authors:  Jean-Xavier Mazoit
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor.

Authors:  D J Cordato; M Chebib; L E Mather; G K Herkes; G A Johnston
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 4.  Pharmacodynamics and pharmacokinetics of thiopental.

Authors:  H Russo; F Bressolle
Journal:  Clin Pharmacokinet       Date:  1998-08       Impact factor: 6.447

5.  Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients.

Authors:  H Russo; M P Dubboin; F Bressolle; S Urien
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

6.  Interaction of thiopental with esomeprazole in critically ill patients.

Authors:  Amélie Marsot; Françoise Goirand; Nadine Milési; Monique Dumas; Audrey Boulamery; Nicolas Simon
Journal:  Eur J Clin Pharmacol       Date:  2013-05-30       Impact factor: 2.953

Review 7.  Pharmacokinetic alterations after severe head injury. Clinical relevance.

Authors:  B A Boucher; S D Hanes
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.